David Roblin

David Roblin is vice president, clinical R&D head at Pfizer Europe.

Articles by David Roblin

With little momentum in developing new new antibiotics to fight antimicrobial resistance, the time is now to emphasize "push" and "pull" incentives and demonstrate how innovation in this area will lead to patient benefit and economic reward.

Latest Updated Articles